PRCS (PRCS) Stock Price & Analysis
PRCS (PRCS) rose 0.00% to USD 27.57 as of June 10, 2026 at 13:50 UTC, according to Nexqual real-time market data.
PRCS last closed at USD 27.57; the session ranged USD 27.63–27.63 on volume of 278 shares. Market capitalization is —, with a 52-week range of USD 24.22–28.24 (NYQ). Source: Nexqual, June 10, 2026 at 13:50 UTC.
Key Statistics (as of June 10, 2026 at 13:50 UTC)
| Price | USD 27.57 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 27.57 |
| Open | USD 27.87 |
| Day Range | USD 27.63 – 27.63 |
| 52-Week Range | USD 24.22 – 28.24 |
| Volume | 278 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (PRCS)
Nexqual's technical model rates PRCS "NEUTRAL" based on 3 bullish and 2 bearish signals across 125 daily candles, as of June 10, 2026 at 13:50 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 50.76 (neutral) |
| vs SMA50 | Above (USD 27.2) |
| MACD | 0.09 (positive) |
Financial Health Score (PRCS)
Nexqual rates PRCS's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 13:50 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MEDX | Horizon Kinetics Medical ETF | USD 34.46 | ▲ 0.82% |
| GNTA | Genenta Science S.p.A. | USD 1.5 | ▼ 16.72% |
| NTII | NEUROBIOLOGICAL TECHNOLOGIES IN | USD 0 | ▲ 0% |
| IDEV | iShares Core MSCI International | USD 88.63 | ▼ 0.07% |
| QLTI | GMO International Quality ETF | USD 26.48 | ▲ 1.18% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 13:50 UTC. This page is informational and not investment advice.